Refractory Nivolumab-Induced Myasthenia Gravis Treated With Abatacept : American Journal of Therapeutics

Secondary Logo

Journal Logo

Advanced Search
Letters to the Editor

Refractory Nivolumab-Induced Myasthenia Gravis Treated With Abatacept

Khokher, Waleed MD1; Bhuta, Sapan MD1; Kesireddy, Nithin MD1; Abuhelwa, Ziad MD1; Mhanna, Mohammed MD1; Iftikhar, Saffa MD1; Horen, Nicholas MD1; Assaly, Ragheb MD2

Author Information

1University of Toledo Internal Medicine, Toledo, OH

2University of Toledo Pulmonary and Critical Care Medicine, Toledo, OH

The authors have no conflicts of interest to declare.

American Journal of Therapeutics 29(5):p e576-e577, September/October 2022. | DOI: 10.1097/MJT.0000000000001405
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Full Text Access for Subscribers:

Not a Subscriber?

Buy
Request Permissions

You can read the full text of this article if you:

Access through Ovid